United States · Industrial & Consumer Products · USD (Thousands) · Annual
Key financials
USD|Thousands
ROE
-
ROA
-263.14%
2024 (actual)
Gross Margin
-
Net Margin
-
Total Assets
$4,575.00K
2024 (actual)
Net Income
-$10,210.00K
2024 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
USD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROA
+262.7 pt
Company
Total Assets
+0%
Company
Net Income
+99.8%
Company
Detailed data
USD|Thousands
Key metrics
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for NeuroSense Therapeutics Ltd.? It covers the balance sheet, income statement, cash flow and Equlion model projections.